A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly
Status:
Completed
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Evaluate the systolic blood pressure lowering effect of aliskiren 150mg and 300mg compared to
ramipril 5mg and 10mg in elderly patients with essential systolic hypertension.